StockTipsArenaBeta

BUY Strides Pharma Science Limited — Nilesh Jain, Centrum Broking

BUYStrides Pharma Science Limited
Strides Pharma Science share price target & all analyst calls

byNilesh Jain, Centrum BrokingHorizon: 1–3 months7 Sept 2026via NDTV Profit

Entry₹1,156Inferred
Target₹1,200
Total upside +3.81% (call closed)
Stop loss₹1,100-4.84% risk
Exit₹1,2008 Sept 2026, 12:09 pm
Target hit+3.81%0.00%upside left
Follow Nilesh Jain for new calls(43% target hit, 47 closed calls)Get alertsWatch STAR for new buy/sell callsGet alertsSee 39 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 7 Sept 2026
4 supporting2 neutral0 opposing
Supports the BUY call (4)

Strides Pharma Science Ltd has received an Establishment Inspection Report (EIR) from the USFDA for its Bengaluru facility. This is a positive development for the company's regulatory compliance and o

BSE · Company Update·19 Aug · 3w ago

(opens in new tab)

HSBC chooses this AC company to upgrade after Q1 results despite peer outperforming

NewsCnbc-Tv18·18 Aug · 3w ago

(opens in new tab)

Voltas could see over 35% profit growth as AC demand stays strong, margins recover: Equirus

NewsCnbc-Tv18·17 Aug · 3w ago

(opens in new tab)

1 advisor has an active long-term BUY call on this stock

Advisor consensus · adjacent horizon·2 Jul · 2mo ago

Neutral / worth noting (2)

Buy, Sell Or Hold: Tata Motors, Vodafone Idea, Varun Beverages, Star Health And Power Finance — Ask Profit

NewsNdtv-Profit·26 Aug · 2w ago

(opens in new tab)

Blue Star among 4 F&O stocks with a sharp rise in futures open interest

NewsEt-Markets·20 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Strides Pharma Science

All analyst calls on Strides Pharma Science

More from Nilesh Jain, Centrum Broking

Every call and its outcome